Sentences with phrase «new biotechnology company»

And this has led to his involvement in the start - up of a new biotechnology company.

Scientists seeking to exploit their discoveries by setting up new biotechnology companies face a difficult choice: They must either spend time learning how to run a business on a lengthy, full - time course such as an MBA, or they take the risk and plunge in at the deep end, taking advice from consultants.

Recent breakthroughs in cancer immune therapy have resulted in new biotechnology companies and value for patient's lives.

Gladstone trainees learned about unique career paths when touring a biology accelerator that helps to launch new biotechnology companies.

Not exact matches

That's the plan for Intrommune, a new New York - based biotechnology company that recently acquired the rights to license the toothpaste technology they intend to apply to food allerginew New York - based biotechnology company that recently acquired the rights to license the toothpaste technology they intend to apply to food allergiNew York - based biotechnology company that recently acquired the rights to license the toothpaste technology they intend to apply to food allergies.

The Hong Kong stock exchange has introduced new rules allowing companies with dual - class shareholding structures and biotechnology firms yet to generate revenue to apply for listings from April 30, as it races to stay ahead of competing bourses in Shanghai, New York and Singapore to attract big technology firms and become the world's largest stock exchannew rules allowing companies with dual - class shareholding structures and biotechnology firms yet to generate revenue to apply for listings from April 30, as it races to stay ahead of competing bourses in Shanghai, New York and Singapore to attract big technology firms and become the world's largest stock exchanNew York and Singapore to attract big technology firms and become the world's largest stock exchange.

• Myonexus Therapeutics, a New Albany, Oh. - based clinical - stage biotechnology company developing transformative gene therapies for limb - girdle muscular dystrophies, raised $ 2.5 million in seed funding.

Bolt Threads, a Bay Area biotechnology startup, said Thursday that it bought New York City - based Best Made Company, an outdoor apparel company that sells clothing, custom - made axes, and artisanal campinCompany, an outdoor apparel company that sells clothing, custom - made axes, and artisanal campincompany that sells clothing, custom - made axes, and artisanal camping gear.

Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology - focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult - to - treat cancers.

New York, NY — Goldman Sachs, in an April report to clients, addressed an ethical conundrum facing pharmaceutical and biotechnology companies in regard to futuristic...

Blockchain companies nonetheless are among the February stocks to watch, along with emerging biotechnology companies and some beaten down stocks that are attracting new interest.

Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011 in ocular melanoma (OM).

Cambridge, MA — December 21, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it closed a $ 30 million Series C financing.

Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first - in - class targeted therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.

AMSTERDAM, NETHERLANDS — December 6, 2017 — Synaffix BV, a biotechnology company that has developed a proprietary site - specific conjugation platform technology to enable differentiated antibody - drug conjugates (ADCs), today announced the launch of a new platform of...

A new generation of meat alternatives is being formulated with the help of biotechnology startup companies such as Beyond Meat and Impossible Foods to more closely replicate the flavor, texture and appearance of real meat, according to market research publisher Packaged Facts in the report Food Formulation and Ingredient Trends: Plant Proteins.

What to Expect in the 6th Week of Pregnancy After working as a chemist at a biotechnology company, Leah is now a freelance writer and enjoys exploring new places.

The «New York is losing» theme continued in Buffalo, where Astorino met reporters at ZeptoMetrix, a biotechnology company owned by Collins.

Many major pharmaceutical companies have stopped researching and developing new antibiotics altogether, shifting more of that responsibility to smaller, nimbler biotechnology startups.

Companies developing things that could benefit from experiments in microgravity, such as biotechnology and new materials, are not flying them currently because they would need to wait years and pay a high price to put them on the ISS, says Gold.

Although project «BioShield» was approved by a Senate committee last week, members of the House are voicing strong reservations about its potentially astronomical cost and negative impact on competition among biotechnology and pharmaceutical companies designing new treatments.

Whether the work is done at government institutions, universities or drug companies, the biotechnology boost to vaccine research is creating new opportunities to do vital work.

The formation of new companies drives growth in new sectors such as biotechnology.

In addition to Abbott and his medical school colleagues, the research team included representatives of Oncodesign, a therapeutic molecule biotechnology company in Dijon, France; Janssen Research & Development, a New Jersey - based pharmaceutical company; andAsclepia Outsourcing Solutions, a Belgium - based medicinal chemistry company.

Headquartered in Tarrytown, NY, a short commute to New York City, we are now among the 10 largest companies in the biotechnology industry.

The group's statement reassured biotechnology companies that their intellectual property rights would be respected and that «facilitating technology transfer» did not mean that they would have to give away patent licences to developing countries that provided them with the genetic resources for new drugs.

I found that out by participating in a test conducted at the Linguagen Corporation, a biotechnology company in Cranbury, New Jersey.

Thanks to a personal connection, one of the most successful biotechnology companies in the United States is apparently the new title sponsor of the Science Talent Search (STS), the prestigious high school science competitions run by the Society for Science and the Public (SSP) in Washington, D.C. New York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outlenew title sponsor of the Science Talent Search (STS), the prestigious high school science competitions run by the Society for Science and the Public (SSP) in Washington, D.C. New York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outleNew York - based Regeneron Pharmaceuticals Inc. will invest $ 100 million over the next 10 years to become the third such sponsor in STS's nearly 75 - year - long history, according to several media outlets.

Many biotechnology companies place so much emphasis on getting new products through the pipeline and into the marketplace that they create a nonstop challenge zone for their employees.

Its Young Entrepreneurs Initiative offers funding support of $ 5000 plus airfare for American scientists and engineers to start new companies in France based on innovative ideas and new technologies, especially in biotechnology, nanotechnology, materials science, and information technology.

As part of my new position, I was involved in developing partnerships with different biotechnology companies, and I started making new contacts.

Brendan Shaw, chief executive of biotechnology industries group Medicines Australia, welcomes the report: «It reinforces the importance of having a strong, stable IP system that allows companies to recoup their costs and commercialize new medicines and vaccines».

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs.

During her career, Ms. Estes has held key leadership positions in some of the most prominent companies in the agriculture and industrial biotechnology fields, including DuPont, Monsanto, and Syngenta, while also working at start - ups and venture funds to establish novel technologies, build new companies and drive innovation.

NEW YORK, August 29, 2016 — The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced today that it will honor biotechnology company Amgen with the 2016 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its September gala in New York CiNEW YORK, August 29, 2016 — The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced today that it will honor biotechnology company Amgen with the 2016 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its September gala in New York CiNew York City.

Drawing on her background in plant pathology and biotechnology, Heard advises agricultural startups, with the goal of launching companies that will bring new innovations to agriculture.

Dr. Srivastava has co-founded a biotechnology company to help find new cures for many human diseases and one of the developmental genes whose role he discovered, Thymosin β4, is currently in clinical trials for patients suffering ischemic damage to the heart.

The researchers have founded a new company, Unity Biotechnology, to develop therapies for the clinic based on this technology.

CAMBRIDGE, Mass., Nov. 16, 2016 — Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that the U.S. Patent and Trademark Office has issued two new patents related to the company's proprietary General Amyloid Interaction Motif (GAIM) platform.

CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.

CAMBRIDGE, Mass., July 13, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data demonstrating that its Zika mRNA vaccine prevented Zika virus transmission from pregnant mice to their fetuses.

Gosselies, Belgium — February 10, 2017 — iTeos Therapeutics SA, a Belgian privately - held biotechnology company applying its expertise in translational tumor immunology to the development of novel cancer immunotherapies, today announced that Michel Detheux, iTeos» Chief Executive Officer, will present at the 2017 BIO CEO & Investor Conference on Tuesday, February 14 2017 at 10:45 a.m. ET in Park North at The Waldorf Astoria in New York, NY.

IDRI is a new kind of global health nonprofit, taking a comprehensive approach to solving infectious disease by combining the high quality science of a research organization with the product development focus and capabilities of a biotechnology company.

biotechnology company developing novel cancer immunotherapies, today announces that it will present new data for its A2A

Gosselies, Belgium — February 9, 2018 — iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announces that it will present new data for its A2A antagonist and anti-TIGIT antibody programs in two oral presentations at the upcoming Molecular Medicine Tri-Conference 2018, taking place from February 11 - 16, 2018 in San Francisco, CA.

Along with colleagues, he founded Ontogeny Inc., a biotechnology company based in Cambridge, Massachusetts that aims to use developmental biology approaches to create new treatments for diseases such as diabetes and Parkinson's.

Increased understanding of the developing brain and how deviations from normal development can increase the risk of neurological and psychiatric diseases has created a rich landscape of opportunity for collaborations between leading academic medical centers and pharmaceutical and biotechnology companies dedicated to identifying new drugs and other interventions to help children.

But while insurers stand to save plenty of money if less women got lymphedema after breast cancer, unlike when new cancer drugs hit the market, exercise offers no immediate profit prospects for pharmaceutical or biotechnology companies — and no multi-million dollar advertising campaign advising patients to query their doctors about it.

Gosselies, Belgium — August 8, 2017 — iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announces that Michel Detheux, iTeos» Chief Executive Officer, will present a company overview at the 2017 Wedbush PacGrow Healthcare Conference on Tuesday, August 15, 2017 at 12:45 a.m. ET in New York, NY.

Dr. Kinet has conducted extensive research and development of new therapies, and he is a Board member of several biotechnology companies, and a Director at UCB Pharma.